What are the key findings from the 2025 AIHW data on Australian mental health prescriptions?

The Australian Institute of Health and Welfare (AIHW) data reveals that nearly 20% of Australians are prescribed mental health medications, led by 5.2 million people (19% of the population) on antidepressants.

Why are medical experts concerned about the rise in Australian ADHD prescriptions?

Experts are concerned that relaxed state regulations and the rapid growth of telehealth platforms have made stimulant medications too easy to obtain through superficial assessments.

How have regulatory changes in Queensland and Victoria affected ADHD medication dispensing?

Regulations in Queensland and Victoria have eased to allow general practitioners and paediatricians to diagnose ADHD and prescribe stimulant medications.

What are the Albanese government's specific targets for reining in NDIS costs?

The federal government aims to reduce the NDIS spending growth rate from its current 10% down to an average of 2% over the next four years. To achieve this structural budget target, the proposed cuts aim to reduce the total number of scheme participants by roughly 160,000 individuals.

How do proposed NDIS funding cuts impact the broader Australian healthcare ecosystem?

The Royal Australian and New Zealand College of Psychiatrists warns that deep cuts will displace vulnerable individuals living with severe mental illness from disability supports.

Economy

Image for illustrative purposes only. Not a real photo.

Rising mental health prescriptions spark national debate

Q: What macro impact does the surge in ADHD and autism diagnoses have on Australian government spending?

The spike in diagnoses is driving unprecedented financial pressure on the National Disability Insurance Scheme (NDIS), which currently costs taxpayers over $50 billion annually.

Written by Liezl GambePublished Jun 11, 2026, 1:27 AM

A sharp rise in mental health prescriptions has sparked intense debate across Australia, with almost one in five citizens now being prescribed antidepressants, psychostimulants, or other psychiatric medications.

According to the latest Australian Institute of Health and Welfare data for the 2025 financial year, approximately 19% of the population—around 5.2 million people—were prescribed antidepressants.

Attention deficit hyperactivity disorder treatments have surged dramatically, with the number of boys aged five to 17 taking psychostimulants tripling over the past decade to reach 10%.

Medical experts and federal MPs have raised urgent concerns regarding the quality of these prescribing practices, pointing to relaxed state regulations and the proliferation of telehealth platforms.

In states like Queensland and Victoria, general practitioners and paediatricians are increasingly permitted to manage ADHD diagnoses and stimulant prescriptions, tasks previously restricted to psychiatrists.

The prescribing boom coincides with a broader spike in ADHD and autism diagnoses, which is putting unprecedented financial pressure on the National Disability Insurance Scheme.

In response to the scheme’s ballooning annual costs, the Albanese government has proposed funding cuts.